Home

About

Product

Research

Pipeline

News

Contact

About TRWR
19474
page-template,page-template-full_width,page-template-full_width-php,page,page-id-19474,bridge-core-3.0.1,qodef-qi--no-touch,qi-addons-for-elementor-1.5.7,, vertical_menu_transparency vertical_menu_transparency_on,side_area_uncovered_from_content,qode-theme-ver-28.5,qode-theme-bridge,transparent_content,disabled_footer_bottom,wpb-js-composer js-comp-ver-6.7.0,vc_responsive,elementor-default,elementor-kit-5,elementor-page elementor-page-19474
 

About TRWR

Who we are

Taiwan Resonant Waves Research Corp. (TRWR) was founded in 2010 in Taipei, Taiwan. Focusing on innovative bioelectronic medicines research and development, we are providing patients with chronic diseases, ranging from metabolism, immunology to neurology related diseases, with innovative adjunctive treatment solutions to help improve their quality of life in our aging society.
 
Our bioelectronic medicines developed from Microcurrent Electrical Nerve Stimulation technology differ from market available electrical stimulation products. Electrical stimulation therapy is mostly used in the field of rehabilitation and pain relief, but rarely for chronic diseases treatment. We believe the application of electrical stimulation therapy in chronic diseases treatment is the trend of the future, providing novel solutions addressing the unmet needs of patients suffering from chronic diseases.

Our Vision

Our vision is to redefine chronic diseases treatment and care in the world to include bioelectronic medicines into gold standard treatment and care in the future.

Our Mission

Our mission is to treat different chronic diseases with our innovative bioelectronic medicines, while

  • protecting patients’ health and safety with our safe, low side effects bioelectronic medicines as complementary treatment solutions

  • ensuring all patients are being cared with our high-quality and affordable bioelectronic medicines

  • improving the life quality and value of patients with chronic diseases

The latest TRWR job vacancies, welcome to join us! ​
Apply Now

With the lifelong passion for beloved Taiwan, we work hard to develop bioelectronic medicines and bring them to the world, hoping to create a blue ocean in the global healthcare industry, helping people live in beautiful and healthy lives.

Chairman

DR.

huang-signature

COMPANY MILESTONES

2022

  • Completed early feasibility clinical study of insomnia treatment, expanding sleep disorder treatment indication
  • Submitted market approval application of type 2 diabetes treatment without predicates to Taiwan FDA
  • Started expanded indications research for type 2 diabetes treatment with electrophysiology and new dosage studies
  • Collaborated with Nangang Biotech Incubation Center and New England Medical Innovation Center (NEMIC) to develop networks with international regulatory experts and strategic partners for US and EU markets development

2021

  • Type 2 diabetes treatment clinical pivotal trial passed GCP inspection by Taiwan FDA

2020

  • Acquired ISO 13485:2016 medical devices quality management systems certification
  • Expanded sleep disorder treatment research with obstructive sleep apnea (OSA) with low-arousal threshold treatment clinical study

2019

  • Started software and hardware development of second-generation medical device for type 2 diabetes treatment with mass production expected in Q1 2024

2018

  • Won 1st prize in Redefining Early Stage Investment (RESI) Conference Innovation Challenge for type 2 diabetes treatment
  • Preliminary animal data showed our type 1 diabetes treatment could delay disease onset

2017

  • Received A+ Fast Track Clinical Trial Program funding from Department of Industrial Technology, Ministry of Economic Affairs, Taiwan for type 2 diabetes treatment

2016

  • Started working with Taiwan FDA on 1-on-1 basis for regulatory consultation of type 2 diabetes treatment

2015

  • Completed clinical pilot study at Saint Mary's Hospital Luodong for type 2 diabetes treatment with 80 subjects

2013

  • Completed clinical feasibility study at Neng-Chun Diabetes Clinic for type 2 diabetes treatment
  • Obtained market approval of“Dragon Waves Resonant Home Care” Electronic Nerve Stimulator as class II medical device for pain relief from Taiwan FDA

2011

  • Started “Dragon Waves Resonant Home Care” Electronic Nerve Stimulator software and hardware development for pain treatment
  • Began preclinical validation of type 2 diabetes treatment

2010

  • TRWR was founded